biote Statistics
Total Valuation
biote has a market cap or net worth of $223.09 million. The enterprise value is $276.14 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, after market close.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
biote has 36.33 million shares outstanding. The number of shares has increased by 71.05% in one year.
Current Share Class | 31.11M |
Shares Outstanding | 36.33M |
Shares Change (YoY) | +71.05% |
Shares Change (QoQ) | -2.45% |
Owned by Insiders (%) | 28.46% |
Owned by Institutions (%) | 39.60% |
Float | 12.20M |
Valuation Ratios
The trailing PE ratio is 29.20 and the forward PE ratio is 14.11.
PE Ratio | 29.20 |
Forward PE | 14.11 |
PS Ratio | 1.05 |
Forward PS | 0.97 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | 6.24 |
P/OCF Ratio | 5.52 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 6.77, with an EV/FCF ratio of 7.84.
EV / Earnings | 38.42 |
EV / Sales | 1.43 |
EV / EBITDA | 6.77 |
EV / EBIT | 6.91 |
EV / FCF | 7.84 |
Financial Position
The company has a current ratio of 1.50
Current Ratio | 1.50 |
Quick Ratio | 1.02 |
Debt / Equity | n/a |
Debt / EBITDA | 2.96 |
Debt / FCF | 3.47 |
Interest Coverage | 4.28 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | 19.89% |
Return on Capital (ROIC) | 82.50% |
Revenue Per Employee | $995,155 |
Profits Per Employee | $37,052 |
Employee Count | 194 |
Asset Turnover | 1.54 |
Inventory Turnover | 3.01 |
Taxes
In the past 12 months, biote has paid $2.93 million in taxes.
Income Tax | 2.93M |
Effective Tax Rate | 25.32% |
Stock Price Statistics
The stock price has increased by +21.93% in the last 52 weeks. The beta is 0.94, so biote's price volatility has been similar to the market average.
Beta (5Y) | 0.94 |
52-Week Price Change | +21.93% |
50-Day Moving Average | 5.52 |
200-Day Moving Average | 6.08 |
Relative Strength Index (RSI) | 55.61 |
Average Volume (20 Days) | 171,491 |
Short Selling Information
The latest short interest is 806,934, so 2.22% of the outstanding shares have been sold short.
Short Interest | 806,934 |
Short Previous Month | 881,497 |
Short % of Shares Out | 2.22% |
Short % of Float | 6.61% |
Short Ratio (days to cover) | 7.82 |
Income Statement
In the last 12 months, biote had revenue of $193.06 million and earned $7.19 million in profits. Earnings per share was $0.21.
Revenue | 193.06M |
Gross Profit | 135.23M |
Operating Income | 39.94M |
Pretax Income | 10.67M |
Net Income | 7.19M |
EBITDA | 40.78M |
EBIT | 39.94M |
Earnings Per Share (EPS) | $0.21 |
Full Income Statement Balance Sheet
The company has $38.23 million in cash and $122.31 million in debt, giving a net cash position of -$84.08 million or -$2.31 per share.
Cash & Cash Equivalents | 38.23M |
Total Debt | 122.31M |
Net Cash | -84.08M |
Net Cash Per Share | -$2.31 |
Equity (Book Value) | -126.82M |
Book Value Per Share | -4.19 |
Working Capital | 23.47M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $39.83 million and capital expenditures -$4.60 million, giving a free cash flow of $35.23 million.
Operating Cash Flow | 39.83M |
Capital Expenditures | -4.60M |
Free Cash Flow | 35.23M |
FCF Per Share | $0.97 |
Full Cash Flow Statement Margins
Gross margin is 70.05%, with operating and profit margins of 20.69% and 3.72%.
Gross Margin | 70.05% |
Operating Margin | 20.69% |
Pretax Margin | 5.99% |
Profit Margin | 3.72% |
EBITDA Margin | 21.13% |
EBIT Margin | 20.69% |
FCF Margin | 10.17% |
Dividends & Yields
biote does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -71.05% |
Shareholder Yield | -71.05% |
Earnings Yield | 3.27% |
FCF Yield | 16.03% |
Analyst Forecast
The average price target for biote is $8.39, which is 36.65% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $8.39 |
Price Target Difference | 36.65% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 17.09% |
EPS Growth Forecast (5Y) | 104.57% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
biote has an Altman Z-Score of 2.25 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.25 |
Piotroski F-Score | 6 |